<DOC>
	<DOCNO>NCT02715232</DOCNO>
	<brief_summary>Background Sex hormone estradiol testosterone modulate human brain structure function tightly connect neuropsychiatric disorder depression anxiety disorder . Using molecular imaging human vivo , investigator show strong influence sex hormone serotonergic neurotransmission via modulation serotonergic receptor transporter . Although , animal study also indicate strong modulatory influence serotonin synthesis degradation , human data potential effect absent . Objectives study The aim study prove modulatory influence sex hormone serotonergic neurotransmission determine enzymatic process involve serotonin synthesis degradation use positron emission tomography ( PET ) humans vivo radiotracers [ 11C ] AMT [ 11C ] harmine . Study design Single-blind , longitudinal study . Transsexuals undergo four PET two magnetic resonance imaging ( MRI ) measurement : 1 . One [ 11C ] AMT PET , one [ 11C ] harmine PET one MRI measurement start treatment , 2 . One [ 11C ] AMT PET , one [ 11C ] harmine PET one MRI measurement 4 month treatment . The investigator propose overall study duration 36 month . Materials Methods : PET measurement perform GE Advance PET scanner . To examine interdependence serotonin activity brain structure function , four MRI sequence perform order ass gray matter volume cortical thickness , gray white matter microstructure , well rest state functional connectivity cerebral blood flow . MRI measurements do 3 Tesla scanner high spatial temporal resolution . Study population 20 healthy female-to-male ( FtM ) , 20 healthy male-to-female ( MtF ) transsexual ( age 18-50 ) free hormone-medication baseline ; 40 healthy control , match sex , age education level . Relevance implication study This first imaging study investigate effect high-dose , long-term opposite-sex steroid hormone serotonin synthesis degradation live human brain use PET . The study lead establishment comprehensive theory serotonergic modulation sex steroid increase knowledge serotonergic role shape brain morphology , microstructure structural/functional connectivity . Results provide essential data well understanding neural sex difference associate difference hormonal state human elucidate neurobiological correlate know gender difference prevalence neuropsychiatric disorder , thus contribute development personalize treatment , reduction personal suffering reduction cost occupational disability .</brief_summary>
	<brief_title>Effects Sex Steroids Serotonin System</brief_title>
	<detailed_description />
	<mesh_term>Gender Dysphoria</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Cyproterone Acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Lynestrenol</mesh_term>
	<mesh_term>Cyproterone</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>DSM5 diagnosis Gender Dysphoria ( DSM5 : 302.85 ; ICD10 : F64.1 ) ( transsexual ) Somatic health base history , physical examination , ECG , laboratory screening , SCID willingness competence sign inform consent form concomitant major medical neurological illness internal neurologic medical history well pregnancy ( positive urine pregnancy test ) breastfeeding DSM5 AxisI comorbidities , determine structured clinical interview ( SCID ) , especially body dysphoric disorder ( DSM5 : 300.7 ; ICD10 : F45.22 ) , schizophrenia spectrum psychotic disorder steroid hormone treatment within 6 month prior inclusion treatment psychotropic agent SSRIs implant stainless steel graft abnormal value routine laboratory screen general physical examination current substance abuse current past substance relate disorder participant participate earlier neuroimaging study use ionize radiation , total radiation exposure dose 20 mSv last 10 year must exceed , specify legislation radiation protection ( Allg . Strahlenschutzverordnung 2010 ; www.ris.bka.gv.at ) failure comply study protocol follow instruction investigate team</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>